Figure 5: Effects of SJ and FSJ on oxidative stress, ACh levels and AChE activity in the hippocampus.

(A) DCFDA dye was used to determine the antioxidant properties of SJ and FSJ in the hippocampus. Data are presented as the mean ± SEM (n = 6–8 mice/group). **p < 0.01, compared with CON-treated group; ##p < 0.01, compared with SCO-treated group. In (B,C) the ACh level and AChE activity in tissue homogenates of hippocampus from CON-treated, SCO-treated, SJ-treated, or FSJ-treated mice were determined using the Amplex red ACh/AChE assay kit. Data are presented as the mean ± SEM (n = 6–8 mice/group). **p < 0.01, compared with CON-treated group; #p < 0.05, ##p < 0.01, compared with SCO-treated group. (D) The effects of SJ and FSJ on expression of ChAT in the hippocampus of mice administered SCO are shown. A representative immunoblot from one of three independent experiments shows the results for the antibodies against ChAT and β-actin. The lower graph shows the quantification of ChAT expressed as the ratio of ChAT/β-actin. Data are presented as the mean ± SEM (n = 6–8 mice/group). **p < 0.01, compared with CON-treated group; ##p < 0.01, compared with SCO-treated group.